Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Results Details (262)

SortShow
Name Institution Why
Lyn Howard Jones, Ph.D.Dana-Farber Cancer Institute Why?
Mei Sheng DuhHarvard T.H. Chan School of Public Health Why?
Stuart A. Forman, M.D.,Ph.D.Massachusetts General Hospital Why?
Peter L. Rosenblatt, M.D.Mount Auburn Hospital Why?
J. Andrew Taylor, Ph.D.Spaulding Rehabilitation Hospital Why?
Mel B. Feany, M.D., Ph.D.Brigham and Women's Hospital Why?
Andrew Kruse, Ph.D.Harvard Medical School Why?
Yihe Chen, M.D.Schepens Eye Research Institute Why?
Reza Dana, M.D.Massachusetts Eye and Ear Infirmary Why?
Adam Kibel, M.D.Brigham and Women's Hospital Why?
Russell E. Poland, Ph.D.Harvard Pilgrim Healthcare Why?
Rebecca Elysia Pappo Rogers, M.D.Cambridge Health Alliance Why?
Can Ozan Tan, Ph.D.Spaulding Rehabilitation Hospital Why?
Jonathan Howland, Ph.D.Harvard T.H. Chan School of Public Health Why?
Michael Philip O'Leary, M.D.Brigham and Women's Hospital Why?
Per Page    Page  of 18last Nextnext
Prev
Search Criteria
  • Muscarinic Antagonists
Click "Why?" to see why a person matched the search.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.